Literature DB >> 19334275

Expression of WNT signalling pathway genes during chicken craniofacial development.

Poongodi Geetha-Loganathan1, Suresh Nimmagadda, Laurent Antoni, Katherine Fu, Cheryl J Whiting, Philippa Francis-West, Joy M Richman.   

Abstract

A comprehensive expression analysis of WNT signalling pathway genes during several stages of chicken facial development was performed. Thirty genes were surveyed including: WNT1, 2B, 3A, 4, 5A, 5B, 6, 7A, 7B, 8B, 8C, 9A, 9B, 11, 11B, 16, CTNNB1, LEF1, FRZB1, DKK1, DKK2, FZD1-8, FZD10. The strictly canonical WNTs (2B, 7A, 9B, and 16) in addition to WNT4 WNT6 (both canonical and non-canonical) are epithelially expressed, whereas WNT5A, 5B, 11 are limited to the mesenchyme. WNT16 is limited to the invaginating nasal pit, respiratory epithelium, and lip fusion zone. Antagonists DKK1 and FRZB1 are expressed in the fusing primary palate but then are decreased at stage 28 when fusion is beginning. This suggests that canonical WNT signalling may be active during lip fusion. Mediators of canonical signalling, CTNNB1, LEF1, and the majority of the FZD genes are expressed ubiquitously. These data show that activation of the canonical WNT pathway is feasible in all regions of the face; however, the localization of ligands and antagonists confers specificity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19334275     DOI: 10.1002/dvdy.21934

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  39 in total

Review 1.  Planar cell polarity signaling in craniofacial development.

Authors:  Jacek Topczewski; Rodney M Dale; Barbara E Sisson
Journal:  Organogenesis       Date:  2011-10-01       Impact factor: 2.500

2.  The beak of the other finch: coevolution of genetic covariance structure and developmental modularity during adaptive evolution.

Authors:  Alexander V Badyaev
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-04-12       Impact factor: 6.237

Review 3.  Neural crest cell signaling pathways critical to cranial bone development and pathology.

Authors:  Yuji Mishina; Taylor Nicholas Snider
Journal:  Exp Cell Res       Date:  2014-02-06       Impact factor: 3.905

4.  A mutation in FRIZZLED2 impairs Wnt signaling and causes autosomal dominant omodysplasia.

Authors:  Howard M Saal; Cynthia A Prows; Iris Guerreiro; Milene Donlin; Luke Knudson; Kristen L Sund; Ching-Fang Chang; Samantha A Brugmann; Rolf W Stottmann
Journal:  Hum Mol Genet       Date:  2015-03-10       Impact factor: 6.150

5.  The canonical Wnt signaling activator, R-spondin2, regulates craniofacial patterning and morphogenesis within the branchial arch through ectodermal-mesenchymal interaction.

Authors:  Yong-Ri Jin; Taryn J Turcotte; Alison L Crocker; Xiang Hua Han; Jeong Kyo Yoon
Journal:  Dev Biol       Date:  2011-01-13       Impact factor: 3.582

Review 6.  Palate morphogenesis: current understanding and future directions.

Authors:  Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res C Embryo Today       Date:  2010-06

7.  A Novel de novo FZD2 Mutation in a Patient with Autosomal Dominant Omodysplasia.

Authors:  Seval Türkmen; Malte Spielmann; Nilay Güneş; Alexej Knaus; Ricarda Flöttmann; Stefan Mundlos; Beyhan Tüysüz
Journal:  Mol Syndromol       Date:  2017-09-08

Review 8.  Holoprosencephaly: signaling interactions between the brain and the face, the environment and the genes, and the phenotypic variability in animal models and humans.

Authors:  Anna Petryk; Daniel Graf; Ralph Marcucio
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-10-22       Impact factor: 5.814

Review 9.  Palatogenesis: engineering, pathways and pathologies.

Authors:  Benjamin Levi; Samantha Brugman; Victor W Wong; Monica Grova; Michael T Longaker; Derrick C Wan
Journal:  Organogenesis       Date:  2011-10-01       Impact factor: 2.500

10.  Comparative gene expression analysis of avian embryonic facial structures reveals new candidates for human craniofacial disorders.

Authors:  S A Brugmann; K E Powder; N M Young; L H Goodnough; S M Hahn; A W James; J A Helms; M Lovett
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.